Balbin, Edzel Dave .

HRN: 28-70-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2026
CEFUROXIME 750MG (VIAL)
03/24/2026
03/31/2026
IV
750 Mg
Q8h
For Elective Open Reduction
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: